Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07100379 · ClinicalTrials.gov registry record · NA

Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study

A NA study, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
128
Enrollment target

NCT07100379 is a NA study that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 128 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07100379, a NA study, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target

Study Summary

Esophageal atresia (EA) is one of the most common gastrointestinal congenital anomalies that affects 1 in 2500 to 1 in 4000 live births. It is characterized by abnormal development of the esophagus, which requires surgical intervention to be compatible with life. Surgical repair of EA is associated with risk of developing esophageal strictures or narrowing, which nearly affects 40% of cases. Strictures can be treated using endoscopic balloon dilation, which consists of introducing a catheter with a balloon into the esophagus via endoscopy and positioning it across stricture followed by balloon inflation. The inflated balloon is held in position for a set amount of time with the goal to dilate the narrowed area. At this time there are no pediatric studies comparing difference balloon dilation times and outcomes. Our study's goal is to evaluate balloon dilation inflation time in treating esophageal anastomotic strictures to understand if inflation time is associated with outcome.

Interventions

  • PROCEDURE Endoscopic Balloon Dilation

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2025-10-28
Est. Completion 2028-06-24
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT07100379

The ClinicalTrials.gov registry entry for NCT07100379 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Endoscopic Balloon Dilation is the first listed.

NCT07100379 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07100379 about?

NCT07100379 is a clinical study titled "Balloon Inflation Time for Esophageal Strictures (BITES): A Randomized Multi-Center Study". Esophageal atresia (EA) is one of the most common gastrointestinal congenital anomalies that affects 1 in 2500 to 1 in 4000 live births. It is characterized by abnormal development of the esophagus, which requires surgical intervention to be compatible with life. Surgical repair of EA is associated ...

What is the current status of trial NCT07100379?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-10-28. Estimated completion is 2028-06-24.

What interventions are being tested in trial NCT07100379?

The interventions under investigation include: Endoscopic Balloon Dilation (PROCEDURE).

Who is sponsoring clinical trial NCT07100379?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.